Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
53
GH Quote, Financials, Valuation and Earnings
Last price:
$108.51
Seasonality move
:
-2.13%
Day range:
$105.68 - $109.59
52-week range:
$29.91 - $112.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.57x
P/B ratio:
32.59x
Volume:
1.6M
Avg. volume:
3.1M
1-year change:
184.75%
Market cap:
$13.8B
Revenue:
$739M
EPS (TTM):
-$3.21
Analysts' Opinion
-
Consensus RatingGuardant Health, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 0 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $100.82, Guardant Health, Inc. has an estimated downside of -4.85% from its current price of $108.52.
-
Price Target UpsideAccording to analysts, the highest upside price target is $130.00 representing 22.69% upside increase from its current price of $108.52.
Fair Value
-
According to the consensus of 18 analysts, Guardant Health, Inc. has -4.85% downside to fair value with a price target of $100.82 per share.
GH vs. S&P 500
-
Over the past 5 trading days, Guardant Health, Inc. has underperformed the S&P 500 by -2.63% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Guardant Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Guardant Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Guardant Health, Inc. reported revenues of $265.2M.
Earnings Growth
-
Guardant Health, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Guardant Health, Inc. reported earnings per share of -$0.74.
Enterprise value:
14.5B
EV / Invested capital:
14.93x
Price / LTM sales:
14.57x
EV / EBIT:
--
EV / Revenue:
16.07x
PEG ratio (5yr expected):
-2.52x
EV / Free cash flow:
-52.85x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$575.5M
Return On Assets:
-28.58%
Net Income Margin (TTM):
-44.18%
Return On Equity:
-8518.58%
Return On Invested Capital:
-36.05%
Operating Margin:
-37.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $535.8M | $692.3M | $902.6M | $191.5M | $265.2M | |
| Gross Profit | $323.5M | $417M | $575.5M | $117M | $171.6M | |
| Operating Income | -$509M | -$514.8M | -$442.4M | -$117.3M | -$99M | |
| EBITDA | -$466.9M | -$471.9M | -$402.3M | -$106.7M | -$89.6M | |
| Diluted EPS | -$4.07 | -$4.24 | -$3.21 | -$0.88 | -$0.74 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $1.1B | $1.3B | $1.2B | $828.9M | |
| Total Assets | $2.2B | $1.7B | $1.8B | $1.5B | $1.3B | |
| Current Liabilities | $102.3M | $175.1M | $226.8M | $197.3M | $236.9M | |
| Total Liabilities | $1.5B | $1.5B | $1.6B | $1.6B | $1.6B | |
| Total Equity | $768.8M | $166.7M | $228.3M | -$60.1M | -$354.5M | |
| Total Debt | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$337M | -$254.1M | -$235.2M | -$51.1M | -$35.4M | |
| Cash From Investing | $247.4M | $391.6M | $288.4M | -$294.8M | -$14.4M | |
| Cash From Financing | $389.1M | $92.5M | -$51.5M | -$2.9M | $4.3M | |
| Free Cash Flow | -$363.4M | -$274.4M | -$274.5M | -$55.3M | -$45.8M | |
GH
Sector
Market Cap
$13.8B
$28.4M
Price % of 52-Week High
94.25%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
0.37%
-1.32%
1-Year Price Total Return
196.14%
-22.19%
Beta (5-Year)
1.579
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$107.48
200-day SMA
Buy
Level
$56.77
Bollinger Bands (100)
Buy
Level
49.03 - 88.55
Chaikin Money Flow
Buy
Level
10.8M
20-day SMA
Buy
Level
$101.61
Relative Strength Index (RSI14)
Buy
Level
69.26
ADX Line
Buy
Level
44.96
Williams %R
Neutral
Level
-29.3997
50-day SMA
Buy
Level
$82.88
MACD (12, 26)
Buy
Level
6.92
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
3.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.8491)
Sell
CA Score
(Annual)
Level (-3.7794)
Buy
Beneish M-Score
(Annual)
Level (-3.2323)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (4.4268)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
Stock Forecast FAQ
In the current month, GH has received 17 Buy ratings 0 Hold ratings, and 1 Sell ratings. The GH average analyst price target in the past 3 months is $100.82.
-
Where Will Guardant Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Guardant Health, Inc. share price will drop to $100.82 per share over the next 12 months.
-
What Do Analysts Say About Guardant Health, Inc.?
Analysts are divided on their view about Guardant Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Guardant Health, Inc. is a Sell and believe this share price will rise from its current level to $60.00.
-
What Is Guardant Health, Inc.'s Price Target?
The price target for Guardant Health, Inc. over the next 1-year time period is forecast to be $100.82 according to 18 Wall Street analysts, 17 of them rate the stock a Buy, 1 rates the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Guardant Health, Inc. is a Buy. 17 of 18 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GH?
You can purchase shares of Guardant Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Guardant Health, Inc. shares.
-
What Is The Guardant Health, Inc. Share Price Today?
Guardant Health, Inc. was last trading at $108.51 per share. This represents the most recent stock quote for Guardant Health, Inc.. Yesterday, Guardant Health, Inc. closed at $108.52 per share.
-
How To Buy Guardant Health, Inc. Stock Online?
In order to purchase Guardant Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GH
Sector
P/E ratio
--
23.66x
PEG ratio
-2.52x
-0.01x
P/B ratio
32.59x
1.84x
Price / LTM sales
14.57x
1.60x
Growth Metrics
GH
Sector
Revenue growth
38.5%
4.85%
Earnings growth
15.15%
11.15%
Revenue (5-year growth)
28.08%
6.45%
Earnings forecast
-$0.49
-$0.20
Profitability
GH
Sector
Profitability FY 2024
$449.2M
$3.6M
Return on invested capital
-36.05%
-30.98%
Return on assets
-28.58%
-27.62%
Return on equity
-8518.58%
-36.69%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Jan
28
Balance Sheet
GH
Sector
Total cash
$580M
$27.2M
Short term investments
$314.4M
$25.7M
Total assets
$1.5B
$79.9M
Long term debt
$1.3B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
